Post Holdings, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-12-31; filed 2026-02-05.
0001530950-26-000020
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationCurrent report: 10-Q
Period ended 2026-03-31; filed 2026-05-07.
0001530950-26-000057
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 9 previous paragraphs and 9 current paragraphs.
8 unchanged; 1 reworded; 0 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Reworded paragraphs (1)
Previous wording
(b)On August 27, 2025, our Board of Directors approved an authorization to repurchase up to $500.0 million of shares of our common stock effective August 29, 2025 (the “Prior Authorization”). The Prior Authorization had an expiration date of August 29, 2027. On November 25, 2025, our Board of Directors cancelled the Prior Authorization effective November 26, 2025 and approved a new authorization to repurchase up to $500.0 million of shares of our common stock effective November 27, 2025 (the “Existing Authorization”). The Existing Authorization had an expiration date of November 27, 2027. On February 3, 2026, our Board of Directors cancelled the Existing Authorization effective February 6, 2026 and approved a new authorization to repurchase up to $500.0 million of shares of our common stock effective February 7, 2026 (the “New Authorization”). The New Authorization has an expiration date of February 7, 2028. Repurchases may be made from time to time in the open market, in private purchases, through forward, derivative, accelerated repurchase or automatic purchase transactions, or otherwise.
Current wording
(b)On November 25, 2025, our Board of Directors approved a new authorization to repurchase up to $500.0 million of shares of our common stock effective November 27, 2025 (the “Prior Authorization”). The Prior Authorization had an expiration date of November 27, 2027. On February 3, 2026, our Board of Directors cancelled the Prior Authorization effective February 6, 2026 and approved a new authorization to repurchase up to $500.0 million of shares of our common stock effective February 7, 2026 (the “Existing Authorization”). The Existing Authorization had an expiration date of February 7, 2028. On May 5, 2026, our Board of Directors cancelled the Existing Authorization effective May 8, 2026 and approved a new authorization to repurchase up to $600.0 million of shares of our common stock effective May 9, 2026 (the “New Authorization”). The New Authorization has an expiration date of May 9, 2028. Repurchases may be made from time to time in the open market, in private purchases, through forward, derivative, accelerated repurchase or automatic purchase transactions, or otherwise.